GreenWave Advisors, LLC projects marijuana lab testing revenues could reach $850 million by 2020.

NEW YORK, June 16, 2015 /PRNewswire/ -- GreenWave Advisors, LLC an independent investment research and advisory firm serving the burgeoning cannabis industry, will publish a report this week that provides a comprehensive and detailed analysis of the marijuana lab testing sector. The report, "Marijuana Lab Testing: An in depth analysis of investing in one of the industry's most attractive plays" discusses current state requirements, the path toward standardization, a state by state revenue forecast, and identifies some of the leading indicators for investment considerations in this emerging sub sector.

"With an eye forward to eventual federal rescheduling or de-listing it is reasonable to assume that uniform national testing and operational standardization protocols will eventually be implemented to assure consumers of an expectant consistency of product. Lab testing services, therefore, appears to us as a prime target for investment capital aimed...